Merck & Co., Inc. (MRK)
113.56
+0.41
(+0.36%)
USD |
NYSE |
May 06, 16:00
113.86
+0.30
(+0.26%)
Pre-Market: 06:14
Merck SG&A Expense (TTM) : 10.88B for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amgen, Inc. | 6.965B |
| Biogen, Inc. | 2.468B |
| Regeneron Pharmaceuticals, Inc. | 2.715B |
| Terns Pharmaceuticals, Inc. | 32.24M |
| Moderna, Inc. | 979.00M |